Company Overview
JAZZ PHARMACEUTICALS PLC
JAZZRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
4,268M
2025 FY
Net Income
-356M
2025 FY
Shares Outstanding
61M
2025 FY
EPS
-5.84USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1232524
Exchange
Nasdaq
Location
US